La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

T. Di Paolo27
Bromocriptine14
T. Di Paolo Sauf Bromocriptine" 21
Bromocriptine Sauf T. Di Paolo" 8
T. Di Paolo Et Bromocriptine 6
T. Di Paolo Ou Bromocriptine 35
Corpus1799
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000E66 C. Gagnon [Canada] ; B. Gomez-Mancilla ; R. Markstein ; P. J. Bedard ; T. Di Paolo [Canada]Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys : regional changes of brain dopamine receptors
000F44 B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
001063 C. Rouillard ; P. J. Bedard ; T. Di PaoloEffects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
001064 C. Gagnon ; P. J. Bedard ; T. Di PaoloEffect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists
001126 P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di PaoloBehavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys
001184 P. J. Bedard ; T. Di Paolo ; P. Falardeau ; R. BoucherChronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3H]spiperone binding

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022